# Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers

> **NCT01766050** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 45 (actual)

## Conditions studied

- Transplant Rejection

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Losartan
- **DRUG:** Omeprazole
- **DRUG:** Dextromethorphan
- **DRUG:** Midazolam
- **BIOLOGICAL:** Belatacept

## Key facts

- **NCT ID:** NCT01766050
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766050, "Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01766050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*